AR215871A1 - Procedimiento para la fabricacion de (ala-aminoacetil)benceno - Google Patents

Procedimiento para la fabricacion de (ala-aminoacetil)benceno

Info

Publication number
AR215871A1
AR215871A1 AR265606A AR26560676A AR215871A1 AR 215871 A1 AR215871 A1 AR 215871A1 AR 265606 A AR265606 A AR 265606A AR 26560676 A AR26560676 A AR 26560676A AR 215871 A1 AR215871 A1 AR 215871A1
Authority
AR
Argentina
Prior art keywords
aminoacetil
ala
benzene
procedure
manufacture
Prior art date
Application number
AR265606A
Other languages
English (en)
Spanish (es)
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Application granted granted Critical
Publication of AR215871A1 publication Critical patent/AR215871A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
AR265606A 1975-11-25 1976-11-25 Procedimiento para la fabricacion de (ala-aminoacetil)benceno AR215871A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48402/75A GB1559977A (en) 1975-11-25 1975-11-25 Amines

Publications (1)

Publication Number Publication Date
AR215871A1 true AR215871A1 (es) 1979-11-15

Family

ID=10448487

Family Applications (1)

Application Number Title Priority Date Filing Date
AR265606A AR215871A1 (es) 1975-11-25 1976-11-25 Procedimiento para la fabricacion de (ala-aminoacetil)benceno

Country Status (28)

Country Link
US (1) US4105790A (de)
JP (2) JPS5265240A (de)
AR (1) AR215871A1 (de)
AT (1) AT348993B (de)
AU (1) AU503657B2 (de)
BE (1) BE848707A (de)
CA (1) CA1068695A (de)
CH (1) CH624383A5 (de)
CS (1) CS196333B2 (de)
DD (1) DD127474A5 (de)
DE (1) DE2653635C2 (de)
DK (1) DK531276A (de)
ES (2) ES453632A1 (de)
FI (1) FI763399A (de)
FR (1) FR2332747A1 (de)
GB (1) GB1559977A (de)
IE (1) IE44030B1 (de)
IL (1) IL50904A (de)
IN (1) IN145003B (de)
LU (1) LU76251A1 (de)
NL (1) NL7613081A (de)
NO (1) NO764012L (de)
NZ (1) NZ182581A (de)
PL (2) PL105799B1 (de)
PT (1) PT65892B (de)
SE (1) SE7613079L (de)
SU (1) SU722481A3 (de)
ZA (1) ZA766696B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02130656U (de) * 1989-03-31 1990-10-29
JPH028457U (de) * 1988-07-01 1990-01-19
US5348969A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
ES2190442T3 (es) 1993-06-25 2003-08-01 Merrell Pharma Inc Nuevos productos intermedios para la preparacion de derivados de 4-difenilmetil/difenilmetoxi piperidina antihistaminicos.
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6930197B2 (en) * 1998-07-02 2005-08-16 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
FR2880887B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof
WO2016009871A1 (ja) * 2014-07-16 2016-01-21 株式会社Adeka 感光性組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543472A (fr) * 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques

Also Published As

Publication number Publication date
GB1559977A (en) 1980-01-30
ES465152A1 (es) 1978-10-01
FI763399A (de) 1977-05-26
CH624383A5 (de) 1981-07-31
DE2653635A1 (de) 1977-06-02
IE44030L (en) 1977-05-25
PT65892A (en) 1976-12-01
DD127474A5 (de) 1977-09-28
JPS5265240A (en) 1977-05-30
IL50904A (en) 1980-02-29
NO764012L (de) 1977-05-26
PT65892B (en) 1978-05-18
JPS61158922A (ja) 1986-07-18
DE2653635C2 (de) 1986-10-02
PL105491B1 (pl) 1979-10-31
FR2332747A1 (fr) 1977-06-24
BE848707A (fr) 1977-05-24
JPS6360004B2 (de) 1988-11-22
DK531276A (da) 1977-05-26
PL193861A1 (pl) 1978-03-28
PL105799B1 (pl) 1979-10-31
AU1962576A (en) 1978-05-25
JPS6120538B2 (de) 1986-05-22
AU503657B2 (en) 1979-09-13
IN145003B (de) 1978-08-12
SU722481A3 (ru) 1980-03-15
US4105790A (en) 1978-08-08
ZA766696B (en) 1977-10-26
SE7613079L (sv) 1977-05-26
LU76251A1 (de) 1977-12-13
CS196333B2 (en) 1980-03-31
NL7613081A (nl) 1977-05-27
NZ182581A (en) 1978-09-20
ES453632A1 (es) 1978-03-16
ATA870976A (de) 1978-08-15
FR2332747B1 (de) 1980-03-14
IE44030B1 (en) 1981-07-29
CA1068695A (en) 1979-12-25
AT348993B (de) 1979-03-12

Similar Documents

Publication Publication Date Title
AR215930A1 (es) Procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
MX4717E (es) Procedimiento para la preparacion de derivados de pirrolidina
MX143890A (es) Procedimiento para la preparacion de compuestos de aglomeracion de alcoxisilano
AR211127A1 (es) Procedimiento para obtener sderivados de 3-amino-4-imino-3-rifamicina.
MX143488A (es) Procedimiento para la preparacion de resorcinas
AR210349A1 (es) Procedimiento para la preparacion de 6-coloro-2(piperacinil)piracina
MX4003E (es) Procedimiento mejorado para la fabricacion de bocadillos
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
AR215871A1 (es) Procedimiento para la fabricacion de (ala-aminoacetil)benceno
MX3635E (es) Procedimiento para la produccion de compuestos de 3-aciloximetilcefem
AR211273A1 (es) Procendimiento de preparacion de nuevas (fenoxi-4-fenil)1-piperazinas
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
MX143639A (es) Procedimiento para la preparacion de compuestos disazoicos tetrarreactivos
DOP1977002589A (es) Procedimiento para la preparacion de nuevas tiazolinas.
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
AR208001A1 (es) Procedimiento mejorado para la produccion de uroquinasa
AR209835A1 (es) Procedimiento para la preparacion de elastasa pancreatica
MX4708E (es) Procedimiento mejorado para la fabricacion de elementos autoportantes
MX3580E (es) Procedimiento para la preparacion de benzamidas substituidas
AR209622A1 (es) Procedimiento para la fabricacion de fosgeno
AR208361A1 (es) Procedimiento para la preparacion de derivados l-piroglutamil-l-histidil-3-alquil-prolinamida
MX3739E (es) Procedimiento para la preparacion de acilamino-penicilinas-6-substituida
MX4238E (es) Procedimiento para la preparacion de derivados de triyodo benceno
MX4134E (es) Procedimiento para la preparacion de los compuestos 1,3-benzoditiol-2-tiona